首页> 外国专利> INDUSTRIAL PROCEDURE FOR THE PREPARATION OF GAMMA-LACTONE ACID 17-HIDROXI-6-BETA, 7-BETA, 15-BETA, 16-BETA-BISMETILEN-3-OXO-17-ALFA-PREGN-4-ENO-21-CARBOXILICO AND KEY INTERMEDIATES FOR THIS PROCEDURE.

INDUSTRIAL PROCEDURE FOR THE PREPARATION OF GAMMA-LACTONE ACID 17-HIDROXI-6-BETA, 7-BETA, 15-BETA, 16-BETA-BISMETILEN-3-OXO-17-ALFA-PREGN-4-ENO-21-CARBOXILICO AND KEY INTERMEDIATES FOR THIS PROCEDURE.

机译:工业过程制备γ-内酯酸17-HIDROXI-6-BETA,7-BETA,15-BETA,16-BETA-BISMETILEN-3-OXO-17-ALFA-PREGN-4-ENO-21-CARBOXILICO和此过程的关键中介。

摘要

Industrial process for the preparation of 17-hydroxy-6β, 7β; 15β, 16β-bismethylene-3-oxo-17α-pregn-4-eno-21-carboxylic acid γ-lactone of formula (I), ** (See formula) ** obtained from the known 15α-hydroxyandrost-4-ene-3,17-dione of formula (III), characterized in that the 15α-hydroxyandrost-4-eno-3,17-dione of formula (III ) ** (See formula) ** is esterified on hydroxy at position 15 with a reactive derivative of an alkanoic acid (C1-6) to produce a 15α-acyloxyandrost-4-ene-3,17-dione of general formula (IV), ** (See formula) ** in which R represents a hydrogen atom or an alkyl group of 1-5 carbon atoms, and said compound of general formula (IV) is reacted, in the presence of an acid catalyst, with a trialkyl orthoformate having 1-4 carbon atoms in the alkyl parts, to produce the 15α-acyloxy-3-alkoxyandrosta-3,5-diene-17-one of general formula (V), * * (See formula) ** in which R has the mi As defined above and R1 represents an alkyl group of 1-4 carbon atoms, said compound of general formula (V) is reacted with trimethylsulfoxonium methylide prepared in situ in dimethyl sulfoxide from a trimethylsulfoxonium salt and a alkali metal hydroxide, to produce the 15β, 16β-methylene-3-alkoxyandrosta-3,5-diene-17-one of general formula (VI), ** (See formula) ** in which R1 has the same meaning defined above, said compound of general formula (VI) is reacted, in the presence of lithium metal, with 2- (2-bromoethyl) -1,3-dioxolane or with a 2- (2-bromoethyl) -dialkoxy-acetal having 1-4 carbon atoms in the alkoxy parts, to produce cyclic 1,2-ethanediyl-acetal of 17-hydroxy-15β, 16β-methylene-3-alkoxy-17α-pregna-3,5-diene-21- carboxaldehyde or dialkoxyacetal of 17-hydroxy-15β, 16β-methylene-3-alkoxy-17α-pregna-3,5-diene-21-carboxaldehyde of general formula (VII), ** (See formula) ** in which R1 has the same meaning defined above and R2 and R3 represent an alkyl group of 1-4 carbon atoms or together form a 1,2-ethylene group, and said compound of general formula (VII) is oxidized with chloranil (2,3 , 5,6-tetrachloro-2,5-cyclohexadiene-1,4-dione) to form cyclic 1,2-ethanediyl-acetal of 17-hydroxy-15β, 16β-methylene-3-oxo-17α-pregna-4, 6-diene-21-carboxaldehyde or dialkoxyacetal of 17α-hydroxy-15β, 16β-methylene-3-oxo-17α-pregna-4,6-diene-21-carboxaldehyde of general formula (VIII), ** (See formula) ** wherein R2 and R3 have the same meaning defined above, said compound of general formula (VIII) a) is cycled in an acidic medium to form 15β, 16β-methylene-3-oxoandrosta-4,6-diene- [ 17 (β-1) spiro5 '] - perhydrofuran-2'ξ-ol alkyl ether of general formula (IX), ** (See formula) ** in which R4 represents a methyl, ethyl or propyl group and the ∼ bond represents the α or β configuration, and said compound of formula (IX) is reacted n with trimethylsulfoxonium methylide prepared in situ in dimethyl sulfoxide from a trimethylsulfoxonium salt and an alkali metal hydroxide, or b) reacted with trimethylsulfoxonium methylide prepared in situ in dimethyl sulfoxide from a trimethylsulfoxonium salt and an alkali metal hydroxide to produce a bismethylene derivative of the general formula (IXa) ** (See formula) ** in which R2 and R3 have the same meaning defined above and the bond ∼ represents the α or β configuration, and said Compound of formula (IXa) is cycled in an acidic medium, and then, from the mixture of 6ξ, 7ξ; 15β, 16β-bismethylene-3-oxo-androst-4-eno- [17 (β-1) spiro5 '] -perhydrofuran-2'ξ-ol alkyl ether of general formula (X) obtained at the end in any one of the sequences of the previous alternative step, ** (See formula) ** in which R4 represents a methyl group, ethyl or propyl and the bond ∼ represents the α or β configuration, the iso mere 6β, 7β is separated by chromatography and oxidized with Jones reagent to produce drospirenone, or the mixture of 6ξ, 7ξ; 15β, 16β-bismethylene-3-oxoandrost-4-eno- [17 (β-1) spiro5 '] -perhydrofuran-2'ξ-ol alkyl ether of general formula (X) obtained at the end in any one of the sequences of the previous alternative step, in which R4 represents a methyl, ethyl or propyl group and the bond ∼ represents the α or β configuration is oxidized with Jones reagent to produce 6ξ, 7ξ; 15β, 16β-bismethylene-3-oxoandrost-4-eno- [17 (β-1) spiro5 '] - perhydrofuran-2'-one (γ-17-hydroxy-6ξ, 7 15; 15β, 16β-bismethylene-3-oxo-17α-pregn-4-eno-21-carboxylic acid) of general formula (XI), ** (See formula) * * in which the ∼ link represents the α or β configuration, and from this isomeric mixture the 6β, 7β isomer is isolated, and if so desired, the drospirenone of formula (I) obtained by any one of the synthetic routes above is purified by cri stalization. ** (See formula) **
机译:工业过程中制备17-羟基-6β,7β;式(I)的15β,16β-二亚甲基-3-氧杂-17α-pregn-4-eno-21-羧酸γ-内酯,**(参见式)**,是从已知的15α-羟基-雄烯-4-烯获得的式(III)的-3,17-二酮,其特征在于,式(III)**(参见式)**的15α-羟基和芳基-4-eno-3,17-二酮在位置15的羟基上被酯化链烷酸(C1-6)的反应性衍生物,可生产通式(IV)的15α-酰氧基-雄烷-4-烯-3,17-二酮**(参见式)**,其中R代表氢原子所述通式(IV)的化合物在酸催化剂的存在下,与在烷基部分具有1-4个碳原子的原甲酸三烷基酯反应,制得15α -酰基氧基-3-烷氧基-雄烷-3,5-二烯-17-通式(V)的一个,* *(参见式)**其中R具有如上定义的mi,并且R1表示1-4的烷基碳原子,所述通式(V)的化合物与三甲基ulf亚砜甲基化物p反应由三甲基ulf鎓盐和碱金属氢氧化物在二甲基亚砜中原位制得,以生成通式为(VI)的15β,16β-亚甲基-3-烷氧基-三芳基-3,5-二烯-17,**(参见分子式)**(其中R1具有与上述相同的含义),所述通式(VI)的化合物在锂金属存在下与2-(2-溴乙基)-1,3-二氧戊环或与2-在烷氧基部分中具有1-4个碳原子的(2-溴乙基)-二烷氧基缩醛,以生产17-羟基-15β,16β-亚甲基-3-烷氧基-17α-pregna-3的环状1,2-乙二缩醛通式(VII)的17-羟基-15β,16β-亚甲基-3-烷氧基-17α-孕烯-3,5-二烯-21-甲醛的**,5-二烯21-甲醛或二烷氧基缩醛,**(参见)**,其中R1具有与以上定义相同的含义,并且R2和R3代表1-4个碳原子的烷基或一起形成1,2-亚乙基,并且所述通式(VII)的化合物被氯腈氧化(2,3,5,6-四氯-2,5-环己二烯-1, 4-二酮)形成17-羟基15β的环状1,2-乙二缩醛,16β-亚甲基-3-氧代17α-孕烯4、6-二烯-21-甲醛或17α-羟基-15β的二烷氧基缩醛,通式(VIII)的16β-亚甲基-3-氧代-17α-pregna-4,6-二烯-21-甲醛,**(参见式)**,其中R2和R3具有与上述相同的含义,所述化合物通式(VIII)a)的化合物在酸性介质中循环形成15β,16β-亚甲基-3-氧代雄烷-4,6-二烯-[17(β-1)spiro5']-过氢呋喃-2'ξ-ol通式(IX)的烷基醚,**(参见通式)**,其中R 4表示甲基,乙基或丙基,〜键表示α或β构型,并且使所述式(IX)的化合物反应n与由三甲基s氧鎓盐和碱金属氢氧化物在二甲基亚砜中原位制备的三甲基s氧鎓甲基化物,或b)与由三甲基s氧鎓盐和碱金属氢氧化物在二甲基亚砜中原位制备的三甲基s氧鎓甲基化物反应产生通式(IXa)**(参见式)**的双亚甲基衍生物,其中R 2和R 3具有以上定义的相同含义,并且键〜表示α或β构型,并且所述式(IXa)化合物为在酸性介质中循环,然后从6ξ,7ξ的混合物中在以下任何一项的末端获得的通式(X)的15β,16β-双亚甲基-3-氧代-和芳烃-4-基-[17(β-1)spiro5']-过氢呋喃-2'ξ-醇烷基醚上一个替代步骤的序列**(参见式)**,其中R4代表甲基,乙基或丙基,键〜代表α或β构型,仅用色谱法分离并氧化6β,7β异构体用琼斯试剂生产屈螺酮,或6ξ,7ξ的混合物;在任一序列的末端获得的通式(X)的15β,16β-双亚甲基-3-氧杂rost-4-eno- [17(β-1)spiro5']-过氢呋喃-2'ξ-醇烷基醚在前述替代步骤中,其中R4代表甲基,乙基或丙基,键〜代表α或β构型,用Jones试剂氧化,得到6ξ,7ξ。 15β,16β-双亚甲基-3-氧杂rost-4-eno- [17(β-1)spiro5']-过氢呋喃-2'-一(γ-17-羟基-6ξ,7 15;15β,16β-双亚甲基-3通式(XI)的*-(oxo-17α-pregn-4-eno-21-羧酸),**(参见通式)* *,其中〜键表示α或β构型,并且该异构体混合物中的6β分离出7β异构体,并且如果需要的话,通过结晶纯化通过上述任何一种合成途径获得的式(I)的屈螺烯酮。 **(请参阅公式)**

著录项

相似文献

  • 专利
  • 外文文献
  • 中文文献
获取专利

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号